Results of the development of a clinical nursing practice guideline for assessment of neutropenia risks in leukemia and lymphoma patients treated with chemotherapy
Article Sidebar
Main Article Content
Abstract
Abstract
The objective of this research was to study the results of development the clinical nursing practice guidelines on assessing neutropenia risks of leukemia and lymphoma patients received chemotherapy regarding its application and satisfaction. A purposive sampling technique was employed to recruits 30 registered nurses who directly take care of the patients received chemotherapy. The research instruments consisted of the nursing practice guidelines of the patients received chemotherapy acquiring febrile neutropenia and questionnaires on general information, the application of the nursing guideline, and satisfaction of using the nursing guideline. Data were analyzed using percentage, mean and standard deviation.
The results showed that the majority of registered nurses 76.70 per cent, had working experience between 1-10 years, 63.30 percent had experience in caring of cancer patients received chemotherapy between 1-5 years and 73.30 per cent had not yet participated in training on caring of cancer patients treated with chemotherapy. The assessment regarding implementation of the nursing practice guideline revealed that the practical feasibility of applying this guideline in the organization was at a high level (50 per cent), easy and convenient of using this guideline was at the moderate level (76.70 per cent) and the effectiveness of this guideline application was at a high level (46.70 per cent). The overall satisfaction score of registered nurses on the application of this guideline was at a high level (Mean 4.06, SD 0.53).
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
References
Thanida Homchin. Effects of nursing care protocol on absolute neutrophil count, nosocomial infections and length of stay in patients with acute myeloid leukemia. Journal of Nurses’ Association of Thailand, North-Eastern Division. 2012;30(2):114-20. Thai.
Puga B, Puga I, Cabrera EM, et al. High risk febrile neutropenia in acute leukemia the experience of a public hospital national program of antineoplastic drugs in adult hospital del salvador 1991-2001. Revista Medica de Chile. 2003;131(9):1023-30.
Balducci L, Lyman GH. Patients aged ≥ 70 are at high risk for neutropenic infection and should receive hemopoietic growth factors when treated with moderately toxic chemotherapy J Clin Oncol. 2001;19:1583-85.
Kanitsap N, Auewarakul C. Outcome of febrile neutropenia in patients with leukemia and lymphoma in siriraj hospital. Siriraj Hospital Gaz. 1991;51(11):857-65. Thai.
Lalami Y, Paesmans M, Muanza F, et al. Can we predict the duration of chemotherapy-induced neutropenia in febrile neutropenic patients, focusing on regimen-specific risk factor?: A retrospective analysis. European Society for Medical Oncology. 2005;1:1-8.
Al-Ahwal SM. Pattern of febrile neutropenia in solid tumors-a hospital based study. Pakistan Journal of Medical Sciences. 2005;21(3):249-52.
Lyman GH, Delgado DJ. Risk and timing of hospitalization for febrile neutropenia in patients receiving CHOP, CHOP-R, or CNOP chemotherapy for intermediate-grade non-hodgkin lymphoma. American Cancer Society. 2003;98(11):2402-09.
Scott S. Identification of cancer patients at high risk of febrile neutropenia. American Society of Health-System Pharmacists. 2002;59(4):S16-19.
Morrison VA, Picozzi V, Scott S, et al. The impact of age on delivered dose intensity and hospitalizations for febrile neutropenia in patients with intermediated grade nonhodgkin’s lymphoma receiving initial CHOP chemotherapy: A risk factor analysis. Clinical Lymphoma & Myeloma. 2001;2(1):47-56.
Blay J, Chauvin F, Cesne AL, et al. Early lymphopenia after cytotoxic chemotherapy as a risk factor for febrile neutropenia. J Clin Oncol. 1996;14(2):636-43.
Voog E, Bienvenu, J, Warzocha, K, et al. Factors that predict chemotherapy-induced myelosuppression in lymphoma patients: Role of the tumor necrosis factor ligand-receptor system. J Clin Oncol. 2000;18(2):325-31.
Pichitra L, Kanaungnit P, Chuchuen C, Noppadol S, Factors associated with febrile neutropenia in acute leukemic patients receiving chemotherapy. J Nurs Sci. 2009;27(2):58-68. Thai.
Petchnoi S. Nursing research: Principles and processes. Songkhla: All-Blind Press.1992 .Thai.
Nattida C. Development of nursing practice guidelines for self-management support among older persons with heart failure, Somdejphajaotaksinmaharaj Hospital, Tak Province. [dissertation] Chiang Mai: Graduate School Chiang Mai University, 2011. Thai.
Duangpen W. The development and evaluation of clinical nursing practice guideline for fever management in patients with traumatic brain injury. Songklanakarind Hospital. Songkla: Prince of Songkla University. 2012. Thai.
Thamonwan Y, Nirobol K. Clinical practice guideline implementation in colorectal disease patients undergoing abdominal surgery. Thai Journal of Nursing and Midwifery Practice. 2018; 5(1):94-111. Thai.
Pharm PS, Silla LMR, Cola CMM, Splitt BI, Moreira LB. Effectiveness of a protective environment implementation for cancer patients with chemotherapy-induced neutropenia on fever and mortality incidence. AJIC. 2013;41:357-9.
CDC. Guidelines for Environmental Infection Control in Health-Care Facilities. Recommendations of CDC and the Healthcare Infection Control Practices Advisory Committee (HICPAC). MMWR 2003;52(RR10);1-42.
Supashutigul, A. HA Update 2014. Nonthaburi: The Healthcare Accreditation Institute (Public Organization). 2014. Thai
